Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM ...
CNNMoney.com - Oct 15, 2007
These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. ...

Discuss   Add this link to...  Tell a friend   Bury

Comments Who Voted Related Links